Wesley S. Lobo - Sep 1, 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Chief Commercial Officer
Signature
/s/ Christopher Melsha as attorney-in-fact for Wesley Lobo pursuant to Power of Attorney previously filed.
Stock symbol
NEPH
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/3/2021, 04:29 PM
Previous filing
Aug 23, 2021
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEPH Common Stock 41.6K Sep 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (right to buy) Award $0 +57.4K $0.00 57.4K Sep 1, 2021 Common Stock 57.4K $8.47 Direct F3
holding NEPH Stock Optoin (right to buy) 114K Sep 1, 2021 Common Stock 114K $8.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 20,557 shares of restricted stock for which the risk of forfeiture will lapse on 2/16/22; and (ii) 20,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/22, 2/16/23, 2/16/24 and 2/16/25.
F2 Options to purchase 28,545 shares vest on 2/16/22 and options to purchase 85,633 shares vest quarterly in 12 equal amounts commencing on 5/16/22.
F3 Options to purchase 14,342 shares vest on 9/1/22 and options to purchase 43,026 shares vest quarterly in 12 equal amounts commencing on 12/1/22.